Stock Comparison

RDY vs TEVA

Dr. Reddy’s Laboratories Ltd ADR and Teva Pharma Industries Ltd ADR side by side — valuation, profitability, growth and risk.

RDY

Dr. Reddy’s Laboratories Ltd ADR

Healthcare

TEVA

Teva Pharma Industries Ltd ADR

Healthcare

Valuation

Market Cap

$10.42B

$41.60B

P/E (TTM)

29.8

59.5

Forward P/E

27.2

17.2

Price/Sales

0.0

2.4

Price/Book

2.6

5.4

EV/EBITDA

14.5

20.9

Dividend Yield

0.66%

—

Profitability

Net Margin

12.72%

9.02%

Operating Margin

14.74%

13.19%

Return on Equity

8.84%

9.69%

Return on Assets

4.01%

5.13%

Growth (YoY)

Revenue Growth

-5.60%

-0.80%

Earnings Growth

-68.70%

72.20%

Price & Risk

Beta

0.2

0.9

52-Week High

$15.40

$36.74

52-Week Low

$11.40

$17.54

Analyst Target

$13.54

$41.20

Compare RDY and TEVA your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.